|

Budesonide EC Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Entocort EC

Pipeline

Phase 2: 1

Top Sponsors

  • University of Utah1

Indications

  • Plasma Cell Leukemia1
  • Multiple Myeloma1
  • Cancer1

Salt Lake City, Utah1 trial

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

Huntsman Cancer Institute at the University of Utah

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.